Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rh Disease”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Early research (Phase 1)Looking for participantsNCT05885412
What this trial is testing

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

Who this might be right for
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Rocket Pharmaceuticals Inc. 9
Very early researchUnknownNCT03130517
What this trial is testing

Efficacy of Intravenous Immunoglobulin in Management of Rh and ABO Incompatibility Disease

Who this might be right for
Haemolysis Neonatal
Assiut University 30
Very early researchLooking for participantsNCT07558538
What this trial is testing

A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

Who this might be right for
ARDS (Moderate or Severe)ARDS (Acute Respiratory Distress Syndrome)
Shanghai Zhongshan Hospital 24
Large-scale testing (Phase 3)UnknownNCT03612869
What this trial is testing

Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)

Who this might be right for
Mucopolysaccharidosis Type IIIA
LYSOGENE 20
Testing effectiveness (Phase 2)UnknownNCT03095079
What this trial is testing

Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 70
Not applicableStudy completedNCT05677997
What this trial is testing

Evaluating the Impact of Resource Navigators to Support LTC and RH Staff During and Beyond COVID-19

Who this might be right for
WellnessBurnout, CaregiverBurnout, Professional+2 more
Unity Health Toronto 123
Testing effectiveness (Phase 2)UnknownNCT03706703
What this trial is testing

Rh-Endostatin (Endostar®) Continuous Intravenous Infusion

Who this might be right for
Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 50
Testing effectiveness (Phase 2)Study completedNCT00424203
What this trial is testing

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCognitive/Functional EffectsDepression+2 more
UNICANCER 40
Large-scale testing (Phase 3)Study completedNCT00295516
What this trial is testing

Doppler or Amniocentesis to Predict Fetal Anemia

Who this might be right for
Rh Isoimmunization
University of Toronto 157
Not applicableStudy completedNCT04874025
What this trial is testing

Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hospital San Carlos, Madrid 815
Testing effectiveness (Phase 2)Active Not RecruitingNCT05625087
What this trial is testing

Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib

Who this might be right for
Breast Cancer Stage IV
UNICANCER 162
Testing effectiveness (Phase 2)Ended earlyNCT04273269
What this trial is testing

A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis

Who this might be right for
GM1 Gangliosidosis
LYSOGENE 5
Early research (Phase 1)Study completedNCT04978675
What this trial is testing

An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaProstate Adenocarcinoma
M.D. Anderson Cancer Center 29
Not applicableStudy completedNCT02713750
What this trial is testing

RH and Adolescents

Who this might be right for
Reproductive Health
The HIV Netherlands Australia Thailand Research Collaboration 77
Testing effectiveness (Phase 2)Study completedNCT00196716
What this trial is testing

The Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 21
Testing effectiveness (Phase 2)UnknownNCT02375022
What this trial is testing

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Who this might be right for
Lung Cancer
Zhejiang University 10
Testing effectiveness (Phase 2)Study completedNCT01801709
What this trial is testing

Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy

Who this might be right for
Metachromatic Leukodystrophy
Institut National de la Santé Et de la Recherche Médicale, France 5
Post-approval studies (Phase 4)UnknownNCT00813332
What this trial is testing

Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)

Who this might be right for
Advanced NSCLCRecurrent NSCLC
Simcere Pharmaceutical Co., Ltd 300
Post-approval studies (Phase 4)UnknownNCT04613284
What this trial is testing

Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC

Who this might be right for
Lung Cancer
Shanghai Chest Hospital 97
Large-scale testing (Phase 3)UnknownNCT04910594
What this trial is testing

Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma

Who this might be right for
LymphomaAnemia
Second Affiliated Hospital, Zhejiang University, School of Medicine 130
Next Page